These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2646539)

  • 21. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features.
    McKenna W; Deanfield J; Faruqui A; England D; Oakley C; Goodwin J
    Am J Cardiol; 1981 Mar; 47(3):532-8. PubMed ID: 7193406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical course of middle-aged asymptomatic patients with hypertrophic cardiomyopathy.
    Hecht GM; Panza JA; Maron BJ
    Am J Cardiol; 1992 Apr; 69(9):935-40. PubMed ID: 1550024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of hypertrophic cardiomyopathy in the elderly.
    Pelliccia F; Cianfrocca C; Romeo F; Reale A
    Cardiology; 1991; 78(4):329-33. PubMed ID: 1889051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history.
    Maron BJ; Spirito P
    Am J Cardiol; 1993 Oct; 72(12):970-2. PubMed ID: 8213558
    [No Abstract]   [Full Text] [Related]  

  • 25. Prognosis of apical hypertrophic cardiomyopathy.
    Refaat M
    JAMA; 2007 Nov; 298(17):2006; author reply 2006. PubMed ID: 17986692
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk factors, clinical features, and outcomes of patients with hypertrophic cardiomyopathy complicated by ischemic stroke: A single-center retrospective study.
    Lu JF; Fan ZX; Li Y; Wang ZY; Ma L; Yuan BY; Yang TT; Liu PJ; Liu GZ
    Front Cardiovasc Med; 2022; 9():1054199. PubMed ID: 36568560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history of hypertrophic cardiomyopathy in cats from rehoming centers: The CatScan II study.
    Novo Matos J; Payne JR; Seo J; Luis Fuentes V
    J Vet Intern Med; 2022 Nov; 36(6):1900-1912. PubMed ID: 36315028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Significance of Ventricular Premature Contraction Provoked by the Treadmill Test.
    Bak MJ; Kwon HJ; Choi JH; Park SJ; Kim JS; On YK; Park KM
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454394
    [No Abstract]   [Full Text] [Related]  

  • 29. Left Ventricular Remodeling in Hypertrophic Cardiomyopathy: An Overview of Current Knowledge.
    Musumeci B; Tini G; Russo D; Sclafani M; Cava F; Tropea A; Adduci C; Palano F; Francia P; Autore C
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33916967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The natural history of hypertrophic cardiomyopathy.
    Autore C; Musumeci MB
    Eur Heart J Suppl; 2020 Nov; 22(Suppl L):L11-L14. PubMed ID: 33654461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial contraction fraction predicts mortality for patients with hypertrophic cardiomyopathy.
    Liao H; Wang Z; Zhao L; Chen X; He S
    Sci Rep; 2020 Oct; 10(1):17026. PubMed ID: 33046745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
    Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A
    Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of evaluating coronary atherosclerosis in adult patients with hypertrophic cardiomyopathy who have chest pain.
    Shin YJ; Lee JH; Yoo JY; Kim JA; Jeon Y; Yoon YE; Chun EJ
    Eur Radiol; 2019 Sep; 29(9):4593-4602. PubMed ID: 30796567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.
    Songsirisuk N; Kittipibul V; Methachittiphan N; Charoenattasil V; Zungsontiporn N; Spanuchart I; Buppajarntham S; Mankongpaisarnrung C; Satitthummanid S; Srimahachota S; Chattranukulchai P; Boonyaratavej Songmuang S; Puwanant S
    BMC Cardiovasc Disord; 2019 Jan; 19(1):1. PubMed ID: 30606129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk assessment of the occurrence of sudden death related to hypertrophic cardiomyopathy in Dakar.
    Sarr SA; Dodo B; Babaka K; Aw F; Bodian M; Ndiaye MB; Kane A; Diao M; Ba SA
    Cardiovasc J Afr; 2018 Jan; 29(1):e1-e5. PubMed ID: 29582881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CMR assessment and clinical outcomes of hypertrophic cardiomyopathy with or without ventricular remodeling in the end-stage phase.
    Cheng S; Choe YH; Ota H; Cui C; Yin G; Lu M; Li L; Chen X; Prasad SK; Zhao S
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):597-605. PubMed ID: 29071521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Women with hypertrophic cardiomyopathy have worse survival.
    Geske JB; Ong KC; Siontis KC; Hebl VB; Ackerman MJ; Hodge DO; Miller VM; Nishimura RA; Oh JK; Schaff HV; Gersh BJ; Ommen SR
    Eur Heart J; 2017 Dec; 38(46):3434-3440. PubMed ID: 29020402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy.
    Philipson DJ; DePasquale EC; Yang EH; Baas AS
    Heart Fail Rev; 2017 Nov; 22(6):879-888. PubMed ID: 28856513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on hypertrophic cardiomyopathy and a guide to the guidelines.
    Sen-Chowdhry S; Jacoby D; Moon JC; McKenna WJ
    Nat Rev Cardiol; 2016 Nov; 13(11):651-675. PubMed ID: 27681577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population.
    Siontis KC; Geske JB; Ong K; Nishimura RA; Ommen SR; Gersh BJ
    J Am Heart Assoc; 2014 Jun; 3(3):e001002. PubMed ID: 24965028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.